Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Recruiting
N/A
Interventional Study
Mesothelioma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 240 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All adult patients with a diagnosis of malignant pleural mesothelioma undergoing
* diagnostic pleural biopsy
* pleuroscopy
* and/or VATS resections
* Participants must be 18 years of age or older.
Exclusion Criteria:
-Any patient who is found to be unsuitable for
* s…
Contacts